An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolo...

por Vehreschild, Maria J. G. T., Ducher, Annie, Louie, Thomas, Cornely, Oliver A., Feger, Celine, Dane, Aaron, Varastet, Marina, Vitry, Fabien, de Gunzburg, Jean, Andremont, Antoine, Mentré, France, Wilcox, Mark H.
Publicado 2022

LB-5. DAV132 Protects Intestinal Microbiota of Patients Treated with Quinolones, a European Phase II Randomized Controlled Trial (SHIELD)

por Ducher, Annie, Vehreschild, Maria J G T, Vehreschild, Maria J G T, Louie, Thomas J, Cornely, Oliver A, Féger, Céline, Dane, Aaron, Dane, Aaron, Varastet, Marina, de Gunzburg, Jean, Andremont, Antoine, Mentré, France
Publicado 2020

Protection of the Human Gut Microbiome From Antibiotics

por de Gunzburg, Jean, Ghozlane, Amine, Ducher, Annie, Le Chatelier, Emmanuelle, Duval, Xavier, Ruppé, Etienne, Armand-Lefevre, Laurence, Sablier-Gallis, Frédérique, Burdet, Charles, Alavoine, Loubna, Chachaty, Elisabeth, Augustin, Violaine, Varastet, Marina, Levenez, Florence, Kennedy, Sean, Pons, Nicolas, Mentré, France, Andremont, Antoine
Publicado 2018